A pair of top Democratic lawmakers asked the U.S. securities regulator on Wednesday to preserve records related to President ...

Donald Trump's World Liberty Financial crypto venture will launch a dollar-pegged stablecoin, it said in a statement on ...

The 100-Index of the Pakistan Stock Exchange (PSX) witnessed bearish trend on Monday, losing 3,882.17 points, a negative change of 3.27 percent, closing at 114,909.49 points as compared to 118,791.66 ...

Pictured is the IQOS store at Narita International Airport in Tokyo, Japan. Philip Morris International (PMI) Duty Free has rebranded to PMI Global Travel Retail, marking a strategic shift towards a ...

Philip Morris (Pakistan) Limited (PMPKL), an affiliate of Philip Morris International (PMI), has decided to purchase all the shares of the company and voluntary delist from the Pakistan Stock ...

Philip Morris International (NYSE:PM – Get Free Report) was upgraded by stock analysts at Argus from a “hold” rating to a “buy” rating in a report released on Friday, Marketbeat reports.

In this article, we are going to take a look at where Philip Morris International Inc. (NYSE:PM) stands against other best FMCG stocks to buy according to billionaires. Historically, the consumer ...

Altria and Philip Morris have differentiated themselves from each other considerably since splitting into two companies. Philip Morris now makes 40% of its revenue from next-gen, smoke-free products.

In this article, we are going to take a look at where Philip Morris International Inc. (NYSE:PM) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money ...

In this article, we are going to take a look at where Philip Morris International Inc. (NYSE:PM) stands against the other low risk stocks. Risk is a key consideration in investing and portfolio ...

Philip Morris is currently overvalued at 23x earnings, making it less attractive compared to its peers like British American Tobacco. PM excels in heated tobacco with its IQOS but faces slowing ...

Philip Morris' premium valuations are justified by the recent US FDA approval for ZYN, attributed to the Nicotine Pouches segment's undeniable growth driver prospects. This is on top of the robust ...